Disclosures for "Downbeat Nystagmus and Causes of Diplopia in SCA27B: A Newly Described, Novel yet Common, Entity with Unique Neuro-ophthalmologic Presentations"
-
Dr. Fein has nothing to disclose.
-
Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care.
-
Dr. Bery has nothing to disclose.
-
Prof. Mu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB BioPharma.
-
The institution of Dr. Abreu has received research support from Adult Polyglucosan Body Disease Research Foundation. The institution of Dr. Abreu has received research support from Sanofi Genzyme. The institution of Dr. Abreu has received research support from Takeda. The institution of Dr. Abreu has received research support from Sangamo.
-
Ms. Steigerwald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vigil Neuroscience.
-
Dr. Rucker has nothing to disclose.